Your opinion matters-Join the PSN
Learn more about how your voice will influence future bladder cancer research through the Patient Survey Network.Read More...
The JPB Foundation 2016 Bladder Cancer Research Innovation Award
The JPB Foundation 2016 Bladder Cancer Research Innovation Award was granted to Dr. David McConkey for his project “Targeting FGFR3 in muscle-invasive bladder cancer.”Read More...
New Conversations Videos!
We are pleased to announce two new Conversations- Let’s Talk about Bladder Cancer videos are now available!Read More...
One woman, two stories…
Writer and BCAN volunteer patient advocate Renata Khoshroo Louwers shares her personal perspective after her first husband Ahmad was diagnosed with Stage IV bladder cancer.Read More...
NEW Immunotherapy “Get the Facts” Available
Immunotherapy is the first new treatment for bladder cancer in decades. Get the facts!Read More...
BCAN Announces 2016 Young Investigator Awardees
The Bladder Cancer Advocacy Network (BCAN) has announced the recipients of the 2016 Young Investigator Awards.Read More...
Nurses Opinion “Clinical Trials Rewarding Beyond Words”
We had worked on the IMvigor 210 trial for two years, so it was an amazing moment for me when TecentriqTM (atezolizumab) was approved in May of this year.Read More...
One Woman’s Story about Dragon Boats, Clinical Trials and Immunotherapy
With the recent approval of TecentriqTM BCAN spoke to Susan from Ohio, about her experience on the clinical trial.Read More...
Nutrition and Bladder Cancer
Learn more, and register now, click here.
- Bladder cancer is the fifth most commonly diagnosed cancer in the U.S.
- Nearly 77,000 new cases of bladder cancer are expected to be diagnosed in 2016.
- More than 16,000 people will die from the disease this year alone.
- Bladder cancer is three times more common in men than in women.
- One in 42 people will be diagnosed with bladder cancer during their lifetime.